P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
about
Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. ColistinThe efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.Drug-drug interactions between moxifloxacin and rifampicin based on pharmacokinetics in vivo in rats.Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients.Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.Pharmaceutical applications of the Calu-3 lung epithelia cell line.Renal Drug Transporters and Drug Interactions.Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats.Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model.Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats. 4. Aztreonam.Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 3. Tobramycin.Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine.Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 5. Oseltamivir CarboxylatePredicting when biliary excretion of parent drug is a major route of elimination in humans.Antiproliferative and cytotoxic properties of moxifloxacin on rat retinal ganglion cells.Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities.Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers.
P2860
Q33798218-6D3F4856-EA49-411C-AA15-D2E8D842B19DQ33798554-FE0A9A3D-910F-4C93-A400-FC441EEA0306Q35076888-92705CA2-8910-402D-BE93-F481FD07E8E0Q35974112-414FA1C0-F038-4C3B-ABBD-BD889201762CQ36571957-1CE839F0-474F-4553-BBF7-57555345C449Q37544479-974C2761-C736-4D2F-9B2B-6FD8D9FEF58AQ37927017-D2B90C35-B161-43A5-8093-08DC9989DD5FQ38111427-A08E816B-C1ED-4F8B-BE2C-B0D5EDD545E1Q39140289-4B42B179-C0FE-4165-823A-CA5967ADB9BFQ39178955-AF4A2920-6C0C-4505-BDCE-780A29E13BF9Q39693073-2A0AC612-A853-460C-B244-43E3BEB31725Q39788312-74F3588B-C4BE-4051-A686-1A9913A7289FQ41284108-78368988-6F67-4E50-AB80-A2932B498C3FQ41830402-9949DD0D-2B46-4916-AB95-C26F09821D32Q41962727-18C81AFA-F336-47C2-B2C5-CC756E9B20E1Q42407634-85331BE8-CA89-4ED4-8D94-3D5DF7293AE6Q42846727-0E0F3243-FCD9-45AB-9FAA-FE6AA9197E77Q44673050-4856E2FF-4A09-48DB-A25E-5CDFC800F79BQ46895816-48A9A168-E8A6-4A7A-B089-27A15F3B42A3Q47101582-9CF7ACD5-8FE0-4041-93A6-345FD7F57F88Q47655472-BF7936EC-22AC-42DA-B45F-DF16CCEC896C
P2860
P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
@en
P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
@nl
type
label
P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
@en
P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
@nl
prefLabel
P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
@en
P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
@nl
P2860
P50
P356
P1476
P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model
@en
P2093
Alain Kitzis
Thomas Harnois
P2860
P304
P356
10.1128/AAC.01253-08
P407
P577
2009-02-02T00:00:00Z